INTERPHARM Europe, a. s.Active
Key figures
Key figures
2025Balance sheet structure
Summary of annual reports2020–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue (net turnover) | 3 487 | 3 365 | 3 832 | 1 407 | 1 349 |
| Profit for the reporting year | 2 936 | 2 824 | 3 215 | 1 000 | 924 |
| Retained earnings of previous periods | -1 627 | 1 310 | 4 134 | 7 349 | 8 349 |
| Total assets | 29 313 | 32 128 | 35 414 | 36 189 | 37 113 |
| Total liabilities | 504 | 494 | 565 | 340 | 340 |
| Total equity | 28 809 | 31 634 | 34 849 | 35 849 | 36 773 |
| Calculated dividends | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Summary: INTERPHARM Europe, a. s.
Overview
INTERPHARM Europe, a. s. (IČO 50242512) is a joint-stock company (a.s.). The company was incorporated in 2016 and has existed for 10 years. Registered office according to the register: Bratislava - mestská časť Podunajské Biskupice. Main activity according to the Statistical Office: manipulácia s nákladom (SK NACE 5224).
People
The company has one statutory representative. The supervisory board has 3 members. The registered capital is 25 000 €.
Financial results
Revenue for 2025 was 1 349 €, down 4,1 % on the previous year (1 407 €). Net profit for 2025 was 924 € (68,5 % of revenue). The company was profitable in 5 of the 6 reported years. At the end of 2025 the company had total assets of 37 113 € and equity of 36 773 € (equity ratio 99,1 %).
Sources and freshness
Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 9. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.